PureTech Health (PRTC) Receivables Refunds (2019 - 2025)
PureTech Health (PRTC) reported Receivables Refunds of $6.4 million for Q4 2025, up 58.98% year-over-year from $4.0 million in Q4 2024, and up 23.04% on a QoQ basis from $5.2 million in Q2 2025.
PureTech Health (PRTC) has 7 years of Receivables Refunds data on file, last reported at $6.4 million in Q4 2025.
- Quarterly Receivables Refunds rose 58.98% year-over-year to $6.4 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $6.4 million (up 58.98% YoY) and the FY2025 annual result came in at $6.4 million, up 58.98% from the prior year.
- Receivables Refunds advanced to $6.4 million in Q4 2025 per PRTC's latest filing, from $5.2 million in the prior quarter.
- Across five years, Receivables Refunds topped out at $34.5 million in Q4 2023 and bottomed at $4.0 million in Q4 2024.
- The 5-year median for Receivables Refunds is $5.8 million (2025), against an average of $10.8 million.
- The widest annual swing landed in 2023, when Receivables Refunds surged 243.94%; it then plunged 88.39% in 2024.
- Tracing PRTC's Receivables Refunds over 5 years: stood at $4.5 million in 2021, then soared by 122.42% to $10.0 million in 2022, then surged by 243.94% to $34.5 million in 2023, then sank by 88.39% to $4.0 million in 2024, then surged by 58.98% to $6.4 million in 2025.
- Per Business Quant, the three latest PRTC Receivables Refunds figures stand at $6.4 million (Q4 2025), $5.2 million (Q2 2025), and $4.0 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Refund Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | - |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | - |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | - |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | - |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | 6.37 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.37 Mn |
| Jun 30, 2025 | 5.18 Mn |
| Dec 31, 2024 | 4.01 Mn |
| Dec 31, 2023 | 34.53 Mn |
| Dec 31, 2022 | 10.04 Mn |
| Dec 31, 2021 | 4.51 Mn |
| Dec 31, 2020 | -14.40 Mn |
| Dec 31, 2019 | -112.41 Mn |